Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors : vimarsana.com

LONDON, Jan. 10, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Robert W....

Related Keywords

London , City Of , United Kingdom , Lauren Williams , Robertw Azelby , Bob Azelby , Susana Noonan , Julia Wilson , Alder Biopharmaceuticals Inc , Sa Noonan Communications , Cascadian Therapeutics Inc , Juno Therapeutics Inc , Immunomedics Inc , Nasdaq , Amgen , Clovis Oncology Inc , Harvard Business School , Management Team , Eliem Therapeutics Inc , Exchange Commission , University Of Virginia , Board Of Directors Chinook Therapeutics Inc , Exchange Commission On , Autolus Board , Christian Itin , Chief Executive Officer , Eliem Therapeutics , Alder Biopharmaceuticals , Executive Vice President , Chief Commercial Officer , Juno Therapeutics , Vice President , General Manager , Amgen Oncology , Oncology Sales , Commercial Effectiveness Unit , Chinook Therapeutics Inc , Cascadian Therapeutics , Religious Studies , Harvard Business , Autolus Therapeutics , Private Securities Litigation Reform Act , Autolu Annual Report , Markets ,